Tempur-Pedic (TPX) has hired Tim Yaggi, most recently the President of Masco's North American Builder division, to fill the newly-created position of COO. Yaggi joins Tempur-Pedic following a difficult year for the mattress/pillow maker. (PR)
Things are all topsy-turvy in the mattress sector. Though both Tempur-Pedic (TPX) and Select Comfort (SCSS) reported weak sales trends (I, II), TPX is up 16.5% premarket while SCSS is off 15.6% as the former company beat estimates and the latter one lagged. The most important message flowing out from the sector is that both sales and margins fell during Q4. Mattress Firm (MFRM) is up 1.1% premarket, while Sealy (ZZ) is inactive, but both look set for some volatility of their own.
Tempur-Pedic (TPX) rips higher in the post session as its Q4 easily beat Street expectations. Net earnings fell 58% Y/Y however, on weaker mattress sales and tighter margins. The company also posted mixed guidance for FY13, expecting to earn $2.55 on revenue of roughly $1.43B. Analysts are looking for $2.72 on $1.43 billion, respectively. The strong upside move likely has to do more with short covering. Recent market data has short interest pegged at 5.64M shares, or 9.3% of its float, which is a formidable position even for a multi-billion dollar company. Shares +17.7% AH.
Tempur-Pedic International (TPX) and Sealy Corporation (ZZ) both receive a second request from the FTC for additional information and documentary materials regarding TPX's proposed acquisition of ZZ. Completion of the transaction remains subject to customary closing conditions, but both companies continue to expect the transaction to close during H113.
More on Tempur-Pedic's (TPX) Q3: The company continues to get hammered by pricing pressure in the sector, with sales in North America falling off 14% Y/Y for the period, only partially offset by a 3% gain in global sales. Gross profit margin slipped 320 bps to 49.2%. The outlook for 2012 sales is lowered to $1.4B and 2012 EPS is taken to $2.55. Shares -14.4% AH. (PR)